<SEC-DOCUMENT>0001193125-21-216469.txt : 20210715
<SEC-HEADER>0001193125-21-216469.hdr.sgml : 20210715
<ACCEPTANCE-DATETIME>20210715164659
ACCESSION NUMBER:		0001193125-21-216469
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210714
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210715
DATE AS OF CHANGE:		20210715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATALYST BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				562020050
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51173
		FILM NUMBER:		211093126

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-871-0761

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d125524d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cbio="http://www.catalystbiosciences.com/20210714" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-07-14_to_2021-07-14">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-07-14_to_2021-07-14">0001124105</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cbio-20210714.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-07-14_to_2021-07-14"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001124105</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-07-14</xbrli:startDate> <xbrli:endDate>2021-07-14</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-07-14_to_2021-07-14">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt:datemonthdayyearen">July 14, 2021</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-07-14_to_2021-07-14">CATALYST BIOSCIENCES, INC.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-07-14_to_2021-07-14">000-51173</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-07-14_to_2021-07-14">56-2020050</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br />of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br />Identification No.)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-07-14_to_2021-07-14">611 Gateway Blvd</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2021-07-14_to_2021-07-14">Suite 710</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-07-14_to_2021-07-14">South San Francisco</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-07-14_to_2021-07-14">CA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-07-14_to_2021-07-14">94080</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-07-14_to_2021-07-14">(650)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-07-14_to_2021-07-14">871-0761</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-07-14_to_2021-07-14">Common Stock</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-07-14_to_2021-07-14">CBIO</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-07-14_to_2021-07-14" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Promotion of Grant Blouse </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;14, 2021, Catalyst Biosciences, Inc. (the &#8220;Company&#8221;) announced that Grant Blouse has been promoted to Chief Scientific Officer of the Company. Dr.&#160;Blouse previously served as the Company&#8217;s Senior Vice President, Translational Research from January 2020 to July 2021 and as Vice President, Translational Research from July 2018 to January 2020. From May 2012 to June 2018, Dr.&#160;Blouse served as Principal Scientist and Project Manager at Novo Nordisk A/S, Haemophilia Enzymology. Prior to Novo Nordisk, Dr.&#160;Blouse was a Senior Scientist at the Company where he helped build the Company&#8217;s Protease Medicines platform including its next-generation hemophilia franchise and its complement programs. Dr.&#160;Blouse has held research and investigator positions at Aarhus University&#8217;s Department of Molecular Biology, Henry Ford Health System&#8217;s Division of Biochemical Research and Wayne State University School of Medicine&#8217;s Department of Pharmacology. Dr.&#160;Blouse earned his B.A. in Anthropology from the University of Delaware, his M.Sc. in Biochemistry from Clemson University and his Ph.D. in Pharmacology from Wayne State University School of Medicine. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the employment agreement dated as of August&#160;27, 2018 between Dr.&#160;Blouse and the Company (the &#8220;Original Employment Agreement&#8221;), as amended by the amendment to the Original Employment Agreement effective as of July&#160;1, 2021 between Dr.&#160;Blouse and the Company (the &#8220;Amendment to Original Employment Agreement&#8221; and, together with the Original Employment Agreement, the &#8220;Employment Agreement&#8221;), Dr.&#160;Blouse will receive a base salary of $414,000 annually. Dr.&#160;Blouse&#160;is eligible to receive an annual performance-based bonus up to 40% of his base salary, subject to his continued employment with the Company on the date the bonus is paid. Dr.&#160;Blouse&#160;is eligible to participate in the Company&#8217;s employee benefit plans on the same basis as generally made available to other employees of the Company, and he will enter into the Company&#8217;s standard form of indemnification agreement for the Company&#8217;s officers and directors. In addition, the Employment Agreement provides that if Dr.&#160;Blouse&#8217;s employment is terminated without &#8220;cause&#8221; (as defined in the Employment Agreement) or as a result of &#8220;constructive termination&#8221; (as defined in the Employment Agreement), in each case outside of the &#8220;change in control protection period&#8221; (as defined in the Employment Agreement), Dr.&#160;Blouse&#160;would be eligible to receive, subject to certain conditions described in the Employment Agreement, the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">continued base salary for nine (9)&#160;months after the termination (the &#8220;Blouse Severance Period&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">accelerated vesting of options that would otherwise have vested during the Blouse Severance Period; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">payment by the Company of the same portion of Dr.&#160;Blouse&#8217;s monthly premium under COBRA as it pays for active employees until the close of the Blouse Severance Period. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if Dr.&#160;Blouse&#8217;s employment is terminated without &#8220;cause&#8221; or as a result of &#8220;constructive termination,&#8221; in each case during the change in control protection period, Dr.&#160;Blouse&#160;would be eligible to receive, subject to certain conditions described in the Employment Agreement, the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">severance payments, equal to the sum of (a)&#160;100% of Dr.&#160;Blouse&#8217;s annual base salary and (b)&#160;100% of Dr.&#160;Blouse&#8217;s maximum annual performance-based bonus, paid in equal installments for twelve (12)&#160;months after the termination (the &#8220;Blouse <span style="white-space:nowrap">Post-COC&#160;Severance</span> Period&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">accelerated vesting of 100% percent of any unvested options; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">payment by the Company of the same portion of Dr.&#160;Blouse&#8217;s monthly premium under COBRA as it pays for active employees until the close of the Blouse <span style="white-space:nowrap">Post-COC&#160;Severance</span> Period. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preceding description of the Employment Agreement is a summary and is qualified in its entirety by reference to the Original Employment Agreement and the Amendment to Original Employment Agreement, copies of which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report and incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships between Dr.&#160;Blouse&#160;and any director or officer of the Company and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to <span style="white-space:nowrap">Item&#160;404(a)&#160;of&#160;Regulation&#160;S-K.</span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Retirement of Howard Levy </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;14, 2021, the Company announced that Howard Levy, the Company&#8217;s Chief Medical Officer, plans to retire from his position. Dr.&#160;Levy&#8217;s retirement will be effective as of August&#160;15, 2021. Dr.&#160;Levy&#8217;s decision to retire did not result from any disagreement with the Company or its management. Dr.&#160;Levy will be joining the Company&#8217;s Clinical Advisory Board effective August&#160;15, 2021 and will provide consulting services to the Company on its hemophilia programs. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d125524dex101.htm">Original Employment Agreement between Grant Blouse and Catalyst Biosciences, Inc., dated August&#160;27, 2018. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d125524dex102.htm">Amendment to Original Employment Agreement between Grant Blouse and Catalyst Biosciences, Inc., effective as of July&#160;1, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:39%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:9%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:35%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:14%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">CATALYST BIOSCIENCES, INC.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: July&#160;15, 2021</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Clinton Musil</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Clinton Musil</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d125524dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g125524nb6.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="21%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nassim&nbsp;Usman,&nbsp;Ph.D.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>President&nbsp;&amp;&nbsp;CEO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>27&nbsp;August 2018</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Grant Blouse, Ph.D. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[ADDRESS] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Dr.&nbsp;Blouse: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter hereby amends and restates the terms of your employment as Vice President, Translational Research of Catalyst Biosciences, Inc. (the
&#147;<B>Company</B>&#148;) and supersedes your previous employment letter dated 2&nbsp;April 2018. In this role, you will report directly to Nassim Usman Ph.D., President and Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While employed by the Company, you agree to perform your duties faithfully and to the best of your abilities and to devote your full business efforts and time
to the Company. Except upon the prior written consent of the Board of Directors, you will not, during your employment with the Company, (i)&nbsp;accept any other employment, or (ii)&nbsp;engage, directly or indirectly, in any other business activity
(whether or not pursued for pecuniary advantage) that might interfere with your duties and responsibilities as Vice President, Translational Research or create a conflict of interest with the Company. This consent will not be unduly withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your base compensation will be $22,083.33 per month ($265,000, annualized), paid periodically in accordance with normal Company payroll practices and subject
to the usual, required withholding. You will be eligible for a review of your salary in connection with the regular review of executive salaries in 2019. You will also have the opportunity to earn an annual performance-based bonus up to 30% of your
annual salary <FONT STYLE="white-space:nowrap">(pro-rated</FONT> for 2018 based on your start date). To receive your bonus, you must be employed by the Company at the time the bonus is paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assist you with your relocation from Kokkedal, Denmark, the Company provided you with (i)&nbsp;a <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus of
$30,000, (ii) a relocation allowance of up to $42,000 to be paid to any vendors retained for the purposes of your move and/or directly to you </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for reimbursement of moving-related expenses, and (iii)&nbsp;up to $3,500 per month for reimbursement of payments on the mortgage for your current home in Denmark until the earlier of the closing
of the sale of such home or ten (10)&nbsp;months after your start date (collectively, the &#147;Relocation Bonus&#148;). By signing this offer of employment, you acknowledge&nbsp;and agree&nbsp;that, in the event that you voluntarily resign from the
Company or if your employment is involuntarily terminated for just cause (as determined by the Company), you&nbsp;will&nbsp;repay the Company said Relocation Bonus&nbsp;as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the termination occurs within 365 days or less following your start date,&nbsp;you will&nbsp;repay&nbsp;100%
of the Relocation Bonus, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the termination occurs within 365 and 730 days following your start date, you will&nbsp;repay&nbsp;50%&nbsp;of
the Relocation Bonus.</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be responsible for any taxes due on the Relocation Bonus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During your employment with the Company, you will be eligible to participate in the Company&#146;s employee benefit plans including, but not limited to, Life,
Disability, Medical, Dental and Vision Insurance, 401(k), Section&nbsp;125 Flexible Spending Accounts in accordance with their terms. The Company reserves the right to cancel or change the benefit plans and programs it offers to its employees at any
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a full-time employee, you will be eligible for <FONT STYLE="white-space:nowrap">paid-time-off</FONT> benefits (PTO), for such things as sick
leave, vacation time or time for personal needs, in accordance with our policies for similarly situated employees. Under our PTO policy, employees can accrue up to 22 days of PTO per year, subject to a maximum accrual cap of 33 days (264 hours). For
example, if your annual accrual is 22 days (176 hours), you may accrue up to 33 days (264 hours) of PTO. Once you earn the maximum accrual, you will not earn additional PTO until you take PTO and reduce your accrual below the maximum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be eligible to receive stock options or other equity compensation as determined from time to time by the Compensation Committee of the Board of
Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event your employment with us is terminated for any reason other than death or Disability (as defined in the relevant equity award
documentation), you will have three months following the termination of employment to exercise the vested portion of any option grant. In the event your employment with us is terminated due to your death or Disability, the vested portion of any
option grant may be exercised within the <FONT STYLE="white-space:nowrap">one-year</FONT> period following the termination of your employment. In no event may any option grant be exercised after the expiration of its
<FONT STYLE="white-space:nowrap">ten-year</FONT> term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should be aware that your employment with the Company is for no specified period and
constitutes &#147;at will&#148; employment. As a result, you are free to terminate your employment at any time, for any reason or for no reason. Similarly, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company is free to terminate your employment at any time, for any reason or for no reason. The <FONT STYLE="white-space:nowrap">at-will</FONT> employment policy can only be changed by a written
document approved by the Board and signed on behalf of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should your employment with the Company be terminated without Cause or as a result of
Constructive Termination (each as defined below), in each case outside of the Change in Control Protection Period (as defined below), you shall be eligible to receive (i)&nbsp;severance payments, equal to the rate of base salary which you were
receiving at the time of such termination, during the period from the date of your termination until the date that is six (6)&nbsp;months after the effective date of the termination (the &#147;<B>Severance Period</B>&#148;), which payments shall be
paid during the Severance Period (or applicable shorter period) in accordance with the Company&#146;s standard payroll practice following the effective date of the release described below and which shall be subject to applicable withholding taxes,
(ii)&nbsp;accelerated vesting as of the time of such termination with respect to the unvested options held by you that would have vested during the Severance Period, and (iii)&nbsp;if you elect to continue your Company health insurance coverage
under the Consolidated Omnibus Budget Reconciliation Act (&#147;<B>COBRA</B>&#148;) following such termination, payment by the Company of the same portion of your monthly premium under COBRA as it pays for active employees until the earliest of
(a)&nbsp;the close of the Severance Period, (b)&nbsp;the expiration of your continuation coverage under COBRA or (c)&nbsp;the date when you become eligible for substantially equivalent health insurance coverage in connection with new employment or
self-employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should your employment with the Company be terminated without Cause or as a result of Constructive Termination, in each case during the
six (6)&nbsp;month period prior to or the eighteen (18)&nbsp;month period following a Change in Control (as defined in the Company&#146;s 2018 Omnibus Incentive Plan, as amended from time to time) (the &#147;<B>Change in Control Protection
Period</B>&#148;), you shall be eligible to receive (i)&nbsp;severance payments, equal to the sum of (a) 75% of your annual base salary determined at the rate at which you were receiving your base salary at the time of such termination and (b) 75%
of your maximum annual performance-based bonus at the time of such termination, paid in equal installments during the period from the date of the termination until the date that is nine (9)&nbsp;months after the effective date of the termination
(the &#147;<B><FONT STYLE="white-space:nowrap">Post-COC</FONT> Severance Period</B>&#148;), which payments shall be paid during the <FONT STYLE="white-space:nowrap">Post-COC</FONT> Severance Period (or applicable shorter period) in accordance with
the Company&#146;s standard payroll practice following the effective date of the release described below and which shall be subject to applicable withholding taxes, (ii) 100% percent of any unvested options held by you will vest as of the time of
such termination, and (iii)&nbsp;if you elect to continue your Company health insurance coverage under COBRA following such termination, payment by the Company of the same portion of your monthly premium under COBRA as it pays for active employees
until the earliest of (a)&nbsp;the close of the <FONT STYLE="white-space:nowrap">Post-COC</FONT> Severance Period, (b)&nbsp;the expiration of your </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
continuation coverage under COBRA or (c)&nbsp;the date when you become eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any severance benefits under this Agreement are conditioned upon your execution of a release of claims in a form provided by the Company, and any severance
payments shall commence on the 60<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day following your separation, so long as you have signed a release that has become irrevocable during such period, with the initial payment including payments
that otherwise would have been made during the sixty day period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this offer letter, any cash severance
payment due to you under this offer letter or otherwise will not be paid during the six (6)&nbsp;month period following your termination of employment unless the Company determines, in its good faith judgment, that paying such amounts at the time or
times indicated above would not cause you to incur an additional tax under Section&nbsp;409A of the Internal Revenue Code and any temporary or final treasury regulations and internal revenue service guidance thereunder
(&#147;<B>Section</B><B></B><B>&nbsp;409A</B>&#148;). If the payment of any amounts are delayed as a result of the previous sentence, any cash severance payments due to you pursuant to this offer letter or otherwise during the first six
(6)&nbsp;months after your termination will accrue during such six month period and will become payable in a lump sum payment on the date six (6)&nbsp;months and one (1)&nbsp;day following the date of your termination. Thereafter, payments will
resume in accordance with the applicable schedule set forth in this offer letter. You agree to work in good faith with the Company to consider amendments to this offer letter which are necessary or appropriate to avoid imposition of any additional
tax or income recognition under Section&nbsp;409A prior to the actual payment to you of payments or benefits under this offer letter. Notwithstanding the foregoing, this offer letter will be deemed amended, without any consent required from you, to
the extent necessary to avoid imposition of any additional tax or income recognition pursuant to Section&nbsp;409A prior to actual payments to you under this offer letter. You and the Company agree to cooperate with each other and to take reasonably
necessary steps in this regard. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement is intended to comply with the requirements of Section&nbsp;409A, including the exceptions thereto, and
shall be construed and administered in accordance with such intent. Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made upon an event and in a manner that complies with
Section&nbsp;409A&nbsp;or an applicable exemption. Any payments under this Agreement that may be excluded from Section&nbsp;409A&nbsp;either as separation pay due to an involuntary separation from service or as a short-term deferral shall be
excluded from Section&nbsp;409A&nbsp;to the maximum extent possible. For purposes of Section&nbsp;409A, each installment payment provided under this Agreement shall be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
treated as a separate payment. Any payments to be made under this Agreement in connection with a termination of employment shall only be made if such termination of employment constitutes a
&#147;separation from service&#148; under Section&nbsp;409A. To the extent that reimbursements or other <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits under this Agreement constitute &#147;nonqualified deferred compensation&#148; for
purposes of Section&nbsp;409A, (i)&nbsp;such expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred, (ii)&nbsp;no right to such
reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall be subject to liquidation or exchange for another benefit, and (iii)&nbsp;no such reimbursement, expenses eligible for reimbursement, or
<FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided, in any other taxable
year. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section&nbsp;409A&nbsp;and in no event shall the Company, any Company affiliates, or their respective
employees, officers, directors, agents and representatives (including, without limitation, legal counsel) be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by you on account of <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B>Cause</B>&#148; shall mean (i)&nbsp;your failure to perform your
assigned duties or responsibilities as an employee of the Company after notice thereof from the Company describing your failure to perform such duties or responsibilities, (ii)&nbsp;your engaging in any act of dishonesty, fraud or misrepresentation,
(iii)&nbsp;your violation of any federal or state law or regulation applicable to the Company&#146;s business, (iv)&nbsp;your breach of any confidentiality agreement or invention assignment agreement between you and the Company, or (v)&nbsp;your
being convicted of or entering a plea of <I>nolo contendere</I> to, any crime or committing any act of moral turpitude. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&#147;Constructive
Termination&#148;</B> shall be deemed to occur if, without your written consent, within 90 days following any of the conditions below, you terminate your employment in accordance with this provision: (A)&nbsp;the Company&#146;s material breach of
this Agreement resulting from the failure of the Company to require any successor to the Company upon a Change in Control to assume the Company&#146;s obligations under this offer letter, (B)&nbsp;a material reduction or other adverse change in your
job duties, reporting relationships, responsibilities and requirements inconsistent with your position with the Company and prior duties, reporting relationships, responsibilities and requirements, provided that neither a mere change in title alone
nor reassignment following a Change in Control to a position that is substantially similar to the position held prior to the Change in Control in terms of job duties, responsibilities or requirements shall constitute a material reduction in job
responsibilities, or (C)&nbsp;the request by the Company or its successor to relocate the principal place for performance of your Company duties to a location more than thirty (30)&nbsp;miles from your then-current principal business location;
provided that (i)&nbsp;you have provided </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
written notice of your intent to terminate employment on the basis of a Constructive Termination within sixty (60)&nbsp;days after the Constructive Termination condition first occurs, and
(ii)&nbsp;the Company fails to correct the Constructive Termination within thirty (30)&nbsp;days after receipt of your written notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that
the severance and other payments or benefits provided for in this offer letter or otherwise payable to you (i)&nbsp;constitute &#147;parachute payments&#148; within the meaning, of Section&nbsp;280G of the Code, and (ii)&nbsp;but for this paragraph
would be subject to the excise tax imposed by Section&nbsp;4999 of the Code (the &#147;<B>Excise Tax</B>&#148;), then your benefits under this offer letter shall be either </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">delivered in full, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">delivered as to such lesser extent which would result in no portion of such benefits being subject to the
Excise Tax, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise
Tax, results in the receipt by you on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section&nbsp;4999 of the Code. If a
reduction is required and no parachute payments constitute nonqualified deferred compensation under Section&nbsp;409A, you shall be able to select which payments and/or benefits are reduced and the order of reduction. If a reduction is required and
any parachute payments constitute nonqualified deferred compensation under Section&nbsp;409A, the reduction shall occur in the following order: (i)&nbsp;options whose exercise price exceeds the fair market value of the optioned equity,
(ii)&nbsp;Full Credit Payments (as defined below) that are payable in cash, <FONT STYLE="white-space:nowrap">(iii)&nbsp;non-cash</FONT> Full Credit Payments that are taxable, <FONT STYLE="white-space:nowrap">(iv)&nbsp;non-cash</FONT> Full Credit
Payments that are not taxable (v)&nbsp;Partial Credit Payments (as defined below) and <FONT STYLE="white-space:nowrap">(vi)&nbsp;non-cash</FONT> employee welfare benefits. In each case, reductions shall be made in reverse chronological order such
that the payment or benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions made <FONT STYLE="white-space:nowrap">pro-rata</FONT> in the
event payments or benefits are owed at the same time). The term &#147;Full Credit Payment&#148; means a payment or benefit that if reduced in value by one dollar reduces the amount of the parachute payment (as defined in Section&nbsp;280G of the
Code) by one dollar. &#147;Partial Credit Payment&#148; means any payment or benefit that is not a Full Credit Payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You understand and agree that by
accepting this offer of employment, you represent to the Company that your performance will not breach any other agreement to which you are a party and that you have not, and will not during the term of your employment with the Company, enter into
any oral or written agreement in conflict with any of the provisions of this letter or the Company&#146;s policies. You are not to bring with you to the Company, or use or disclose to any person associated with the Company, any confidential or
proprietary information belonging to any former </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employer or other person or entity with respect to which you owe an obligation of confidentiality under any agreement or otherwise. The Company does not need and will not use such information.
Also, we expect you to abide by any obligations to refrain from soliciting any person employed by or otherwise associated with any former employer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
offer letter and the confidential information and/or inventions assignment agreement between you and the Company represent the entire agreement and understanding between you and the Company concerning your employment relationship with the Company
and supersede in their entirety any and all prior agreements and understandings concerning your employment relationship with the Company, whether written or oral. Except as specifically provided in this offer letter, this offer letter can only be
amended in a writing approved by the Board and signed by you and a duly authorized officer of the Company. Any waiver of a right under this offer letter must be in writing. The Company will require any successor to all or substantially all of its
assets or businesses to assume this Agreement and perform the Company&#146;s obligations hereunder. This offer letter will be governed by California law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of federal immigration laws, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment
in the United States. Such documentation must be provided within three (3)&nbsp;business days of the effective date of your employment, or your employment relationship with the Company may be terminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Grant, I look forward to your participation in the Company&#146;s future success. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page Follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Nassim Usman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nassim Usman, Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">President&nbsp;&amp; Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted and agreed to this</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">29<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of August, 2018</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Grant Blouse</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant Blouse, Ph.D.</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d125524dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this &#147;<B><I>Amendment</I></B>&#148;) is made effective as of 1&nbsp;July
2021 (the &#147;<B><I>Effective Date</I></B>&#148;) between Catalyst Biosciences, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), and Grant Blouse, Ph.D. (&#147;<B><I>Employee</I></B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RECITALS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>,
Employee and the Company previously entered into an Amended and Restated Employment Agreement dated 27&nbsp;August 2018 (the &#147;<B><I>Amended and Restated Employment Agreement</I></B>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company desires to amend the terms of the Amended and Restated Employment Agreement to (i)&nbsp;reflect Employee&#146;s
promotion to Chief Scientific Officer, subject to approval of the Board of Directors of the Company, (ii)&nbsp;adjust Employee&#146;s base salary and annual performance bonus opportunity, and (iii)&nbsp;modify the terms of Employee&#146;s severance
benefits (collectively, the &#147;<B><I>Modifications</I></B>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Employee has agreed to the Modifications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the promises and mutual covenants contained herein, and intending to be legally bound hereby, the
parties agree that the Amended and Restated Employment Agreement is amended as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Promotion</U></B>. The last sentence of the first paragraph of the Amended and Restated Employment
Agreement is hereby deleted in its entirety and replaced with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;Subject to approval of the Board of Directors of the
Company, you shall be promoted to the position of Chief Scientific Officer of the Company.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Base Compensation and Bonus Adjustment</U></B>. The third paragraph of the Amended and Restated
Employment Agreement is hereby deleted in its entirety and replaced with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;Effective as of June&nbsp;1, 2021, your base
compensation will be $34,500 per month ($414,000 annualized), paid periodically in accordance with normal Company payroll practices and subject to the usual, required withholding. You will be eligible for a review of your salary in connection with
regular review of executive salaries in 2022. Beginning with respect to the Company&#146;s 2021 fiscal year, you will also have the opportunity to earn an annual performance-based bonus up to 40% of your annual salary. To receive your bonus, you
must be employed by the Company at the time the bonus is paid.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Severance Period and <FONT
STYLE="white-space:nowrap">Post-COC</FONT> Severance Period Adjustments</U></B>. The definition of &#147;Severance Period&#148; shall hereby be the period from the date of Employee&#146;s termination until the date that is nine (9)&nbsp;months after
the effective date of the termination, and the definition of <FONT STYLE="white-space:nowrap">&#147;Post-COC</FONT> Severance Period&#148; shall hereby be the period from the date of Employee&#146;s termination until the date that is twelve
(12)&nbsp;months after the effective date of the termination. Should your employment with the Company be terminated without Cause or as a result of Constructive Termination, in each case during Change in Control Protection Period, you shall be
eligible to receive (i) severance payments, equal to the sum of (a) 100% of your annual base salary determined at the rate at which you were receiving your base salary at the time of such termination and (b) 100% of your maximum annual
performance-based bonus at the time of such termination, paid in equal installments during the Post-COC Severance Period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No Other Modification</U></B>. Except as provided
herein, the provisions of the Amended and Restated Employment Agreement shall remain in full force and effect following the adoption of this Amendment and this Amendment shall not constitute a modification or waiver of any provision of the Amended
and Restated Employment Agreement except as provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Governing Law</U></B>. This Amendment
shall be construed under and be governed by California law without giving effect to California conflict of laws principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Signature Page Follows] </I></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties hereto have duly executed this Amendment as of the
date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>CATALYST BIOSCIENCES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nassim Usman</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: &nbsp;&nbsp;&nbsp;Nassim Usman, Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: President&nbsp;&amp; Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Grant Blouse</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant Blouse, Ph.D.</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Signature Pages to Amendment] </I></B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cbio-20210714.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 7/15/2021 9:14:03 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  xmlns:cbio="http://www.catalystbiosciences.com/20210714"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"

  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.catalystbiosciences.com/20210714"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />

    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbio-20210714_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbio-20210714_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cbio-20210714_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 7/15/2021 9:14:03 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cbio-20210714_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 7/15/2021 9:14:03 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cbio-20210714.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g125524nb6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g125524nb6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP!#  (! 0(! 0(" @(" @(" P4# P,# P8$! ,%!P8'!P<&
M!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_VP!# 0(" @,# P8#
M P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# S_P  1" !B NX# 2(  A$! Q$!_\0 'P   04! 0$! 0$
M          $" P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01
M!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT
M-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)
MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9
MVN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $"
M P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A
M<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$
M149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7
MF)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;G
MZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K!^(?CNU\ >'9KRYPTC I!%G
MYIGQP![>I["MB^O([*UDFED6*.$%G=N%4#J37S1\4_B1<?$?Q!YPVK86K,MH
MG^R< L?]H@?EQ7Q_&7$T,HP=X/\ >STBOSD_)?B[+N>_P]DTLPQ%I?!'67^7
MS_(W_P#AICQ!_P ^FC_C%)_\77&_&G]OC4O@_P"$)KZ:UT&:_D!6RM"DN;F3
M_OO.T?Q'MTJG8V,VJZC#:V\;37%RXCC0=68]/\?H*^9?^"B7PPUKX9?&RQCU
M2\2^L[[3EEL)(X#''$ Q$D0^8[F5N2>X9>!W_#Y<3<1?59XRG6DX1:3>EDWM
M_7IW/V?AOA/(L;FM/ XB$5=.5M;R4;72_7RO;8^AOV,?^"D^L_&[XS6_A7QA
MIN@6']JQN=-N=/26(><H)\IP\C@[E!PP(Y4C!SQ]G1OYBYK\0?!_BR^\ >+=
M+UW2F6/4]%NXKVU9EW*)8V#+D=QD8([@FOV4^!_Q2T_XT_"S1_%.F-_H>M0"
M<(>L+])(SP.4<,OOMK]+\,>*J^94:F$QU3GJPU3>[B]/G9_FCQ?&3@C#9/B:
M.-RZDH4:BY6E>RFM>M[<T=N_*V=91117ZJ?B84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% 'D_[2?[7/A[]FV/3;&YM]2\1>+?$!*:+X
M:T>#[1J6JMG!*KD!(QU,CD  '&2,5Y2/VN?VCM/F;4K[]F.Z.@#YS':>+;&;
M4E3L?)#99O\ 8 S].:@^ 'A*'Q[_ ,%4?CIXFU%6N;OP7IFCZ+I+2$L+..XM
MVEE"#MDKV_OMZU]9LFZ/;5 >>_LZ_M/>$_VH?!\FK^%KZ23['+]FU&QN83!>
MZ5<8^:">(\JX(89&5.TX8]:[Z_O8]/@:::1(88E9Y'<@*J@9))] .?PKQWX>
M?LBVOPH_:Z\7?$O0]46QT_QMI20:IH<5MMCGOUE5_MN_=C<5W@J%&6E=B237
M._\ !3GXSWWPQ_9MFT+09&7QA\2+N+PIH:(,OYMTP21Q_NQE@#V9DJ0+?[!_
M[==I^VSI/BJXCT5O#\WA^^18+>2X,LEW8RAC;W1RB[=YCF4J-P!C/S&KW[0O
MQO\ C-\/O'\=CX"^"Z_$#06M(Y6U3_A)[/3MLS,P:+RI2&.T!3N'!W>QKR3X
MH>&;?]AK]K_X(:QH=M]C\!>(-)A^&.I*@&(W1RVGR2=,MYCGY^N%DSVS]D 8
M@YI@?%^I_P#!1?XX:/\ &#3? %Q^SO!%XPUBQ?4K+3F\:6>9[="P:3S-OEC&
MQN"P;CI7K'P3^/'QT\:?$FPTWQI\"8_!7AR=93<ZPOB^PU#[*51B@\F)M[;F
M 7@<;L]J\_\ BI_RF7^%O_8B7W_H5S7UX:; \1_;I_:_?]C;X06OB*WT%O$V
MJ:AJ"6%GIBW'D><2DDLC;@KGY(XV/W>XZ<D>J?#OQO9_$GP%HOB+3Y$EL=<L
M8;^W93D&.6-7'_H5?-2ZW:_M/_\ !3*[TMH5U+PG\$]!E2X5UW6YUF__ ';9
M[,5M=Z8/0B2I?^"9_C&\\(VGC[X*ZVSIK'PDUZ6WL(W^9I-(N'::S<'N K$>
MR[![! >F?MJ?M/3_ +)?PIL?$T&C1:ZUYK5II)MWN3;A!.Q'F;@K9VX^[CG/
M45Z]7R;_ ,%DO^36-#_['+2?_1CU]94@/&_$7[5TG@C]LO1?A9KFA-8Z=XLT
ME[W0-<$Q:._NHR3-:,FW",J#=G<<[D&!N&?8]X]:\(_X*$?!+4_BQ\!KC5?"
MT+#X@>!;B/Q%X7N8O]=!=0,KNB]F\R-638<AB0"#7)^+?V_;>^_X)Z6_Q6\.
MVI?Q#X@ACTC2]-";I!K4LIMC"$)^;9*)' _B1,]Q3W [+P1^V%)XW_:'^)'A
MN'1[.W\"_#&T U7Q7-J 6(7P57DM_**_=C7S2[[OE,7(^92>'_X;@^*GQIW7
M_P &_@O<>)/"1D9;7Q%X@U>+2+?5$4E?,@@?]Z8VP2K$#CJJURWQ3_9A\1_!
MO_@D;XN\*V:/>^.-0TV36?$<MNWF3:E>2SK<7QW#_6-Y8D3C[PCX]*^@OV-O
M'7A_X@_LS>!;SPS>V-]I=OH=E:?Z.X;[,\=NB-"P'W60C!4\C\1E^8'GG@/]
MMOQGX;\9Z1X?^,7PGUKX>W'B&\33M)U2PN4US3;ZY?[L+-;;GA9L$@NN.#DJ
M!FMCX\_''X[>!OB5<:=X%^!]IXZ\-QP1/%J[^++/3FDD9?WB>3*=PVGC/0]J
M]Y:+<^<^_2GU('Q6?^"@7[0 ^+G_  @?_#.NG?\ "7G2CK8TW_A-[/<;,2^5
MYWF?ZK[_ !MW;N<XQDCU3X%?'7X]>-OBA8Z;XX^!=IX)\,S+*;G6$\766H-;
ME8RT8\F-M[;G 7@<9R>!7./_ ,IB[?\ [)0W_IS6OJ&/_5K]*H!U!8+UXH/2
MN)^-/Q*_X0/PS^X9?[4N_DME/S;/60CT'\\5PYACZ."P\\3B':,5=_Y+S>R\
MSHPN%J8BK&A25Y2=OZ\EU.+_ &B/B8M[(WA^QD9E5O\ 3G7HQ&<19]NI_ >M
M>3G]VA]A3II9+JXDFDD:225S([MRSL>I/UK/O?B;X?\ AUJ'VC6(KC4)(X_.
M@T^#@W+C@;V/"1^IY)P< ]:_FO$UL;Q+F]H+WINR72,5WWT2U?=WMN?L5&GA
MLFR^\GI'5OJV_P!6]$>]? #X6/HEJ=:U*W\N\G&+5&Y:&,]6([%OS ^IKB?^
M"EOP$A^+7[.5YJ=O'NUKP@6U.U?(W-$%_P!(CR>QC&_'=HD]ZX-/^"E.N;?^
M17T;@9XNI, ?E_G%4=0_X*::E?I]FNO!^D7-G-F.Y3[7)^\C8891D8Y4D<\>
MM?KF>4\@R+(GEN855"$TUKK*4G]I12;;3L[I65ET/D.&:N=8_/(9EEM-SJ4Y
M*6FD4E]EMM)<RNK7N[L^ U&^+_>'U_G_ %K[N_X)'_M!^=I.K?#G4)EW6.=3
MTD,.6B9@)X\_[+%7'?\ >/V&!\;_ !=\.Z7X7^(FIV^A2/)H4LOVC3?,_P!9
M%;OEDC?_ &X_N'U*Y&0:M_ 'XOW/P&^,OA_Q5;;F73+I3<Q+UN+9ODFC'N8V
M;'H<'L*_!>%<Z_LC-Z>)YO<3Y9-:IQ>C:?5;23\DS^M^,LCAQ%P_4P]./O2B
MIPNK-32O&_9O6+[)L_:&BLWPKXHM?&6@V>J:?*EQ8:A ES;3*>)8W 96'U!%
M:5?UY&2DE*.J9_!\HRC)QDK-!1115$A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!EZMKDECX@T^R5%*WB3.6/5=FT]/?=6H.E<]XB_Y'S0O^N%W_
M "BKH1TK@P=:<ZM>,GI&22\ER0?YMLVK048P:ZJ__DS7Z'F'Q:^+7B[3/B+8
M>$? WA_1]:UB:P?5;ZZU?47L;#3;<2"*)28XI9)))7\P*%7:HA<L1E0W+?%#
M]M*3X2?!+PWXHUSPGJNDZUK5V(KKP_<.#=:?!!OEU&XW 8DCM[6&><, !(%C
M QO%=!\7_ WCBP^*UCXQ\"MX6N[EM+?1M2TS7KB>UAN8_-$L$R30QRLKQN90
M5,9#K+U4J">9T[]D#5_&OBK2-2^(WBV\\47&C>')=*CFLF.GF2YNYY9+]C&@
M"B)HEM(4&2=D;;N3D]YB;GQP^,GQ \%2:5J'A'0O NO>&]8N+"R@NM0UZYM+
M@SW<RQ(VR.UE0Q#S(VW;]Q!/RYQFEXK_ &KM0^%GCCP'X7\5:3I,>M>(2\VO
MR:9?R7%CX>M6F%K:S&22*-G$UU+;0@%$P7E/(3)3X?\ [/WB/PY\!/#O@O4-
M6T_4&\(^([.?3[MI)&:32K/44GMXI,H/WZVZ+$<9!* [CDU3^)O[%UG\:M;^
M)%]XFU74H;CQC#!IM@-/U":*.RL[:(-;!U 7,BW33S\9 ,BC)P#0!TA^//B#
M7/'?Q8\,Z#X>L=0UGX?V%C<:9'/?^2FL3W5M+,L3MM/DC=&$W?,/FR<8KG5_
M;BL]5LK>XT?1;O5VT[PA<^+O$EG;Y-UHJ1*RQV6S;A[J6>.>,(2N/LTC'^$-
MB> /A-\;/AK\0_$'B:*+X:^)-3\7:3HL&J2W>L7MBJ7EE:M%.\:QV;@QR2.S
M+RN!@8YXZ/X4?LQ:O\+M"^,2Z7JVF^']>^(GB6^UK2]6L+1;B33EE@B6 RI*
M@5VCE61RG*D2'!!8D !\+OCO\2_B=X2FO;'POX!O)-2T^+4=$OK'Q1+=:3)N
MD026UU,EL9(IEC<,ICCD1]K<KBK7[*'QU\>?'K1;C7->\->$]$T%;K4=.A;3
MM:N+Z[>ZLKZ2SDW(]M$@B9H)65@Y;&S*C)QF_LZ_L]>(/ /QDU+Q5JVB_#_P
MF+[3&LKNS\(R3-%K]T9DD^W72O#"B2(%8*%5V_TB3=(V%QV7[+OPFU#X&?"D
M^']2N+.\NFUS6M3$EJ6,?EWNJ75Y&OS '<L<ZAN,;E.,C!H \QTW]N77KOXM
M:QI3^'_"0T'2?&Z>"L#Q$RZY.[M"HNH[-H LD:^>K,%EW!8Y" =N*Z37OVL]
M2&I:EH.C:#8WWBR;QA/X2T.UN+YH;6Z\FQCO9;JXE6-C$D<32$JJNS%5 ^]D
M>>Q_L6>+3\2?%ES_ &?\-TL?$?CA?%47B5C,_B+2H ]L_D0*;8*LG[@C=YVT
M><WRGH>N\0_LN>)+37=0\4Z'>Z&_BK3?'-SXKT2*[EFCLY[>XT^.PFMKAE0M
M&S1^:0Z*^UA&>1D4 .\0?MEZMX&\$>((=>T7P_IWC;PWK6GZ+>PR:PT>APB^
M*&VO'O&A#I;E&(;=%O$J,F""KG2N/VEO&^C^"K:&^\!V;>,M6UR'0M&BM=8$
MFBZP98'N1>1W?E[UMTABF9PT7F9B*JK;ESGQ? +QXVB>+?$4\O@F3QMXRU*T
MN;_1YEENO#]S8VT!MX[!Y'B\TY4O*9A$#YA4;"@P>=\&?LA>-/!'@ZZO=%O/
M"'AS6K3Q5%XHT'PU9-/+X;T=%M7M9K-&**ZK/'-,S-'"JI(X98^.0#L)OVGO
M&7A"ZT'3/%G@6WTG5M4\7V7AEI[?46N--NX;B":47=K*8U=]IB*-%(B%3WZ9
MS/@?^U5XX^->OQM!I/PQL=';6[[3'@E\5S_VT(K2ZF@>06HM"I<K"9 OF8VG
M);'-3ZI\"OB1\1]2\.ZMXLU_P_\ :=+\:V7B)-(L?,:QTFRMK::)H(9C$LDT
MSO+O9Y%13C "@<\]^S]^R]XM^"'B>.23P/\ !?49!KVHWY\2"XF37%M[R\N)
MSM/V$YD6*<QX\W! QNP:8%OX??\ !01_'WP(T7Q0OAEK#7;SQ%I6B7^D3W!4
M6L5_=)'#=1R[,2QO"ZR*0 "P9"05..@\-_M.>-O'^HS:UX;\"V>L?#^U\02>
M'WNQJ;1ZO<"&Z-K<WT5KY1C:WCF5_E:42,D3L%Y4'A]1_8*\1#X:?"&ST_7M
M-L=<\"W6E1:^H>1K'7+&SNQ=I&!LW"2.4;HWVKCS95) <UU?@WX'_$SX6W5U
MX7\,ZUX7M? UWXDGUU-3G:9M9L+6XNS>7%@D'EF%R7>1%F:7*H_W"5!HZ 3?
M"_\ :=\9_%3XEZEI]KIGPVL]#TOQ-?Z"XN?%$ZZU+':7#PO,EH+4J68(75#*
M!CJPZU+^S[^U3XJ^/.MV>H6WA/18_!NH7UYI[/#K7FZUH4D!E53J%H8U6+S&
MB*[4D=D,D>0025Y_X3_LR^*?AE\6=8U1_!_PBU*#5?%6I:ROB1[B5?$%G;7=
MS)+M0&R(\R-'*@><%.,9 J'P]^S?X[T'XLZ/XNU:T^'^I:QX72\DG\3Z7$UG
MKWC%&M9HH+:[A6*.!!N:-F)F<9A7;Y>20: >O?'_ .,]Q\%/"&DZI#I\6I-J
M6OZ9HICDF,(07=U';F0'!SL\S<%P-V,9%>2#_@H8W_")_'":7PTUKK/PECUR
M[TZWEG86WB.VTW*O(DNSY&$GEK(H#%//C(W;A7:_$7X:^,/CS\"/!=KK,.BZ
M+XLM=8T37M7@CE=K2![6[AN)X8V 8DX1E4G@D?>QS7F?Q1_8#U_X@_ #XF>'
M[+Q!IND>*?%/B77M7T?4(B[0QV>I@QRV=SE,[)(697"AMKK&ZDLBD&@'?>*?
MVF/&FM^-?$NE_#[P7I?B6/P+;V\FMF^U9K*6[N9H/M L[)5BD#RK$48M*8T)
ME10?O%?;K*\%W9PS%9(?-17V2C:Z9&<,.Q'<5X-X@^!_Q&\ ?$#QCJ7P[U+P
MC';_ !#AM9+]]8>99M#OX;=;8W=NJ1N+@-$D1\J0Q@/$/FPQ ]9\+6_B&TU[
M5H=5DTB?1H1;)I,T7F?;9L1 3M= J$#&3)7R^"IYP:0'@_[)<RC_ (* _M/Q
M_P ?VGP\^/;[!(*^GB<"OCGXQQZU^Q!^VIKWQJO+*_U3X5^.M*MM.\2OIT/V
MBZT2Z@7;#<O$/F:$ 8+I]WS6R.%SZ!JO_!4_X!Z3X/766^)FAW$+*&6VMUDE
MO6SCY?LX7S ><<@8J@/H.1]O\)^M?(_C*\T;]H3_ (*9Z3%J%[91Z#\!=(-S
M*+J=(T?6;_#1JH)^?RH8E?/\+J!]7_LY:_XJ\0_$[XA?M%?$2/4?"?@8Z&;/
MPQI%](RRVVE0N9GNY8,_NY)?+5@&&[]X0,KM)Y7]@O\ 8-\&_'?X&-\1OBSX
M1TOQ1XK^(^I7'B02WZLTEM;3MNA08( !&9.!TD Z 41 ]F_;TT#P[\:_V5?%
M6E0:YH\6M6%J=8T25;V(21:A:@S0%/F^\679GT<]:Z[]D/\ :$M?VH/V;_"O
MC2W^6;5K0+>QA=ODW<9,<Z8Z@>8K$>JE3WKD3_P2^_9_C *_"GPKD$8_<OVY
M_O5P_P"PU!:?LS_M)?%/X%_N[>Q6\7QGX6CW'_D'72JDL*Y_YXRH% /)!<]J
M *_Q4_Y3+_"W_L1+[_T*YKZ=^*7Q#TWX2?#O6O%&L2-%I?AZRFU"[91EO+C0
MN0!W8XP!W)KY@^*CJ?\ @LU\+ES\P\"7Q([CY[BM+_@J1<W'Q/\ "7@?X+Z3
M=20ZU\5]?BMYPH_U6F6N)[N9CV5<1'!'//IB@ _X)LIHG@WX%W'B_P 0:YX?
MM_%WQ4U*?Q9JZMJ$(DA-PQ>& Y.1LC897LTC^M9?QI^(/ASX%?\ !0?X=^/=
M/UC1Y]+^)=LW@GQ$+:ZCE99\A[&X8!C_ ,M L1;C"^O?TI?^"9/P!*@GX5^$
MW./O/;LS-]23D_CWKSG]K3_@EW\-]1_9X\4?\*[\"Z'X=\965I]OTB\L86CF
M$\#"41C!_P"6@0Q\C@OFC0"S_P %D'W?LLZ*/3QEI/\ Z,>OK.O@7]N[]H'3
M?V@/^"9'P]\?1W$:6NJ>(-'GO<_\NL\;2+<H?]R1)!] *]\/_!4?X  _\E0\
M/_@DW_Q%(#WQQ\O'7UKX'^&?P/M;/_@K;K'@NWN&C\#^$X)/B1I^@E0;2#5;
MB.WMVD5>V))7E7J%(&%!R:^D/ __  41^"OQ+\8:;X?T+XA:+J6L:M.MM:6L
M2R[YY#T490#)]S7E/PYD7_A]GX^7<N[_ (5O <9YQ]HL^:: ^OG3=C%?/6M?
M\$S/ARGB:^USPG<^,?AIK6I2-+=W7A'7Y].%P6);YHLM%M!.0 @ S@<<5ZI\
M?O%GB[P/\+-3U3P/X;@\7>)+5 UKI<UX+1+GD;LN0>BY(4<L0 *\<\"?\%7O
M@UXDC:UU[Q)-X#\06H"7^C>(K*:RN;"8</&Q9-K%6R.#SC.*D#BOCC8?&K]@
MWP__ ,)_8_$C4/BKX#T%U;7]"\0V<"7\=F6"M-!<Q*&>1=P/S 8QDAP<#Z^\
M/:Q;^(=&M=0M)!+:7T*7$#C^*-U#*?Q!!KXT_:M_;*T7]L7X:ZU\(_@>UQX^
M\5>,(ET^]O;2VD73=#LG8>=//<.@3!4,B@'DMD9( ;[!\!>%X_ _@O2-%@+-
M;Z/8P6,1/4K%&J#]%%,#YS?_ )3%V_\ V2AO_3FM?4,?^K7Z5\N/,O\ P^0@
MCW+O_P"%4.=N>?\ D)KV_&OIV[O8["P>::6.&.%<N[MM5![FE*22NQI-NR*W
MBCQ/:>$=%N+^]9EM[==S;1DG)P !ZD\5\R>-O%EQXY\2W&H7&1YAVQ1YXBC'
MW5'\SZDUT'QH^*S>/M7^RV<^[2+7&T8QY[]2Y]AT ]L]ZX'4=2@TVV,UQ,D,
M:_>9CC_)]NIK^>^.^*)9IB5@<&[THOI]J6UU;=+:/?5]K?J_"^1K!47BL0K3
MDNOV8_H^_P!Q5\6>*;;PEH\EW<[MJG:BK]Z1CT ^OZ &O'?#'A'Q'\<?&S6N
MFV<VI:I='S&[1PIG[S,>$0=,G^9 KV#0?V;?&'[1FOPS7$,_AWPG&=T-Q=Q%
M99@?XTA8@DL.A8!0,<GG/U?\,?@_X=^$.B-8Z#ID-DD@7SY0-TUT5& TC]6/
M)]ADX K]*X$X66587V^(7[ZHM?[JZ1\GUEYZ=#XWB?.WCJ_LZ;_=QV\WW_R_
MX)XY\/\ _@GMX=TWP/=6OB*0:MK=]$5-RCO'%8L5('E*"-V"<Y;KC[HR:^-/
MBC\,]4^$'CB\\/ZRB+>V>T^9'_J[B,C*R(>X//T((."*_515"]*\*_;6_9F3
MXT>!6U;3(%7Q1HL9>W('-Y",LT!^N2RGLW'0FOF_%G@7^V<#]?PD?]HHI_\
M;\=W'U6\?.ZZZ?4>&O&']DXSZGB7^XJM)_W9;*7DGM+RL^A^<OC7PTNM6'FP
MQ_Z9;K\I'61>Z_U%>?AL#/W:]:4\?Q*WN,%3[CL03T['CJ*XGXA>&S:W#7T
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M !3K5WXK\2:2VF:9'-I=K!=:<PU%V6\69KA%\W]R/).Z#D*)<!LY/2N5^/\
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M&X"LF]_94TV72)+.#Q!KNGPZA8BPU80);C^TU%S/= MF(B+$MS<'$810LI7
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M2.5S/%\9+C_A-Y- F\*:]#??8[B^@_TBQ<74<+(F5VW!*;V=0OF! 3G)7!H
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M&";XA>*OAGJOA<0RB:WT;3;F"[:3;^[(9SMVAN3WP*^2/V#/^"B_PO\ V3_
M7C7PWXPU/4[?5KCQOJNH+';:?)<*(G:-%.Y>,DHW'M7O_AK_ (++_ WQ9XDT
M_2K/6M<:\U.ZALX%;1Y55I)9%C7)[#<PR>U("GK+[?\ @M/HW7GX8RC_ ,G&
M/]*P[VT3_@FA^UW-K$UU/%\&?C/?F%X$;$'A?6V8.)&4X5()5\SE,85<,,1J
M3T7B6/\ XW-^'6"G_DF5P"0.,_;&KZ ^/7P1\/\ [0_PEUKPAXDM5NM+UJ Q
M,=H9[=_X)H\]'1L,#ZCN,@@'@_PS&/\ @K_\2!UQ\/\ 3>O_ %W%9_\ P2VY
M\>?M(!O]9_PM+4R01SC<<5YE_P $U].\:>&?V^O'OAWQX?.U_P '^#;;0%O?
M+(_M&VM[E!;W&23NWQ,ASG)R,_-FNP\5>*]8_P"":'[1OCOQ5?>%]<\3?"GX
MJ7Z:U=:CI%OYTWA>]"[91-'QNB=F+ALKQ@<E3N;WL!]K,<"OF'_@L$I_X8!\
M8[1@FZTS /\ U_V_6N$^*G_!2_3?VI_#5[\//@5H_B'QAXF\56SZ:^K"TDM-
M/\/).IC:YFD(W HK%N@''4GY38_;\^%$?P)_X)+77A"._N]7;P^FDP37<VXS
M7D@OX'ED(8LPW,6;!)P"!GBD!TT'PZ_; :%3'\1_@[LVC;_Q([@<8'M7N'P!
MT/X@Z/\ #[[/\2]8\/:YXD^U2-]IT>V>WM?(./+7:_.X8.3T-?/MM_P6K^"%
MO;QQ_;/%F44*<:%+S@8KT+]GK_@H=X%_:P\1:MH?@)M5O-;TO3GU'R=3LI+&
MWD =8U4RX;;EW0$A6(&2 <8I <!=?L&?%+X%>.]8U+X%_%&S\->'=;NY+U_"
MFNV!NM+L)';<PM\;O*4L3PB*0."6 &-&U_:T^)W[-?Q,\)>'/CKH_A&;2_'%
M\FEZ5XE\*7$WV:WNV("Q74-P%90V5^=3@9Z$!BN/IG_!6O2?A-=RZ#\<O"/B
M+X:>*; F*:6.T>\TG4&!QYEM,OS,C?>'! ! W$UQ?Q.^*#?\%9_'7@OPQ\/]
M#UZS\ ^$]?AU[7_%&J6?V:WE$60MO;+DL[N&/)QC.2N!FJ]0/O57WTM-C!#-
M[FG5( 1D5Y3^UG^SNGQ_^'$EI:1VL.N:>1-IUQ(N-I!^:(MU"N./3(4]J]6I
M&&5/TKS\TRS#YCA*F"Q<>:$TTU^J[-;I]'J=N79A7P.)AB\,[3@[K_)]T]FN
MJT/R2U'3;G1-2GL[R"6UO+.5H9H9!AXG4E6!]P0:X_X@:+):A=7L6D@O+,B0
MR1,4==O*N".0P('(Y YZU]U_M_\ [+YU.*7QYH5O(]Y&J+JUK#&6,Z#"BX '
M.Y1M# #E0#VKY$_LRZ !^QW3#T\ECD?E7\/\2\.XWAO-986I=I:QE_-#H_)]
M&NC7W_V1PCQ5A\UP4,=1M?:<7TE;5/R>Z?56/TV_9U^,EG\=O@WH/BBT^7^T
MH/W\?&89U)25#CT<'\,'O7<5^>/[ WQU'[,OBK4M!UU=07PGXCN(YH+GR',>
MCW &UFD7'^KD4H"X^[Y0)&"2/T(L[E;J/S%D616 *E3E2.Q!K^P.".**.>99
M#$QDO:))3752].G-:Z];=#^6^..&99+FE2C!?N9-NF^CB^GK&]FM^NS3<U%%
M%?8'QP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SWB+_D?-"_ZX7?\HJZ
M$=*Y[Q#_ ,CYH7_7"[_E%70CI7F8#^/B?\:_]-TSIQ'P4_\ #_[=(XGQ7\+K
M7Q=X_&H:@K36BV*VJPI<RQ%F\QF)8(P#(00,-D=>,9JY\2/ R^-/A?K7A^U^
MRVC:C826EN9(=T,+%<)E!P4!"Y7C(&*\[_:,TO5->\?:?X7TV2YMD^(%I]CN
M+V(G_0%LY1.S?5TF=!C';VJ/P-XZUS5OV?O''CI(9M-U36#<7UK"\)N'TY;>
MWCM^(O\ EH5>"20(/O;L=Z\;!9E06;5,#2HVFVW*7>R3=W;6RE2Z_P#+RR^&
M1Z^)R^L\OABYU;Q224>UW9:7ZN-3I]C7XD:3_!2_F_TA_#O@&1&U-+Q]%E0R
M6 "V<EOYD;F#,<Y9_F;RCF)0F>2U9WAG]GCQ)H7A.W\.S:EI-WIMQ<:1>7EW
MYDJW$#V;PO)%$A4AXV^SQ(A9PR*3PVU0>:^(GQM;0M T^WT'XHMJ5E>7]X5U
MMQ9>6##:0RK:?:%A>.1R\NY8DA+R#='N7RVS6T+XQ7EUH.K:I>^,O[#UC7H-
M"O9K::ZM;6WTN*XLH&>=6EB<P1O()(][K(N[Y0 Y#+]8?/G9?%CX!:W\2?%N
MK:@K>'UO-0TZSL[*YEN)3/X;DANII?M5NHCP[-NC?!*#? %)9>:]#\&>"9M$
M\:^+-:OI;>YGUR[@^R%02UK90V\:I"2?28W,N!QF<]\UX7IOQAU+PK>ZIXVN
MK@ZE:Z'H-E-JL\:"3[7IL&IZK%-,I6- S)"%G)2--_E8"J&Q6G??%[Q)9_$G
MP?;WGBEK.75DTU9O#Z6D7VY#=/,TCF.2,&>-%,:&6*1?(^SNS))EA0!WL7PB
MU"7X)S>!YKJR\N_TR_L9[M&;?"TQ?RG2/;\P'F'.67!48R#4>M> /%/C70O%
M*WEUH>GWOB"WM--1+*:6XBAMXG<SY=D0EG$LZA0OR_)DGG'EL?Q M?#_ ( T
MJ\7XI7%C?6/AJ=8KF7['<37M]#)@V;@Q?O&C<A# @69MV"<@&M+6OC#J%NFH
MG5/&*^"?LLVM2V*QVEL/[3NH+UHXX"9$/F,D8B'E)B2;SB0QV\ 'HWQ*^$-Y
MXN\;S7]K:Z"RWD-C%]ON=RW^F&WN'D9X"$8$E9#M^9"K#.2#QUVA:*^D^+=;
MOI)(]NK-"T2 G<!'&$.?Q].W6O _%WQX\3:-\2==M8_%"^<UI>YTNTLH[IO#
MHBMHW,LT#1K,?+)D=9@\D4YVH$3<IJ;QW\8-0\/Z4DWA;QE!XRMU&H!=5FMK
M:Z^PH$L"[B2",)*($FFF.U<'&Q@VR@#Z2\U309E&?:OG>#Q5XJUXV&GZ9\0H
M[BQ;3M9U%=2TI[/4Y)FMA8"&-Y_LZ1-MDGF.$C7*;%)R&:J?A7X^>(O$'AVZ
MUJ/7#<>-%L'NK#P.MI'Y=VG]E_:(2 %^T8DEPWG;M@R8MN[F@#Z4$RGU_*E+
M8KYDD^*NM1>!)KD_%CPW=:?]IA,6HKJ-K:RE_L[O);O<-9F"'.(Y5B>/>/G0
MOC%==X]^,ADM_",-UXP;PEI-Y82S:OJWV>WBDAO1;VTT%I+YHDC@:6.:6780
M680[5//(![9YRT>:-V.:^<]0^-7B2U\8.B^),ZS#J5G9VGAMK".'^U-/DM()
M)KXJ094VEYY=X?9']G\DJ6W$S>&-;\;W=I-<W7C+6)O[-\*:3XE=/L%I&MU=
M7/VD2PMB+(M_]& $8PX,C$R'"T ?1%%-5LL?:G4 %%%% !1110 U8@HH,1Q]
MX_X4ZB@",VV1C=D>].CC\NG44 0R64<TBLRJS*<J2 =OTIPAV_Q'ZU)10!&U
MN''/3N",@_A0ELL:A5^51T51A14E% #2ORXIJVP5RV?F;O@9%244 -1-E(T.
MYL[C]*?10 U8\#[S4&//\34ZB@"/[/C^)J<4RFW/XTZB@"/R?FSN;CM3G3=W
M*_2G44 1^1\N,DKC&.U.$7.<TZB@ Q36CW4ZB@!GDY/WFQZ4&')'.=IR,T^B
M@ HHHH **** &NF\>E-^S_[3?G4E% $1MO\ IH_IUI\47E+C.:=10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 <]XB_Y'S0O^N%W_**NA'2L/7K
M">;Q=I-RD;-#;PW*R,#]TL(]OYX/Y5N*<J*\[ QE&MB&UO-->?[N"_-,Z*TD
MX4[?R_\ MTC,DU>R;Q"VF?:K7^T3 ;K[+Y@\XQ;@OF;<YV[N,],D50M_B#H;
MQZ&RZQIF/$W.D_Z0H_M+]T9?W()^?]VI?Y>P)Z5S/Q'^&5[XI\=2ZQI[1V>K
M:/;6<^CWC=//CDNO-MWYSY4L<JHX]'##YD4KYSX:^$'BR'X<>';UM'MUU;P7
MX6TFVLM+O'5I);RW\NZGAAD63RXS(\4$!D((!C)&5'S>B<Y[#-\7/#,'B:31
M7\0:8NK6X<O:FY D4HAD=3_M+&"Q7[P49(P,U+X+^)WAWXC^9_8.O:7JWE*L
MCQVMTDK1HWW690<A6[$C!'(SUKRK4?"GB1/%VIV>DZ#X@T^QUJ[O;B^LYGL[
MK19!)'*5NX9&(GANI'\O=&OR"0OE<,9SG7G@GQMX]\,>'K>QT&_\*7>C^%W\
M,RW][/%YZ-=FSCGDB6*5B4AC@>7<S M(L04$$L #U+QSKO@OQ+\/+74M:U32
M[SPW<3PS0S?;/]&O9%?=&HV'$P++GRSN5MIRIQ75>'=:L_%NCPZCI][#?6-V
MN^&>!PT<BY[$9'4?7L>>*\>T/PIXF^%WB"&-]'EU;0]!U%KZPCTE(X_*M[NW
ME22&.*23+-!,FXC/,=T-N2A!V?V?+?SY;^_N-$U#3[R\UC5Y\7$0B;3%DNHB
M;=_FPS2A4EW1[HR0V'/!8 ZS3?B_X9U?Q!>:7:^(M+GU"Q61IX!=*6C\O_6X
MYP3'T< G8<!L<"DT3XO^%_%&E275CXBTRYM;>6"&22.X7$;S,$A#>GF,0%/1
MCP,UQ7AFSUR+PU8^%Y_!4B2:''> ZG//;_9P?*GCBFM3N+M+-Y@#;E38KR[F
MS@/S>B^ O%6JZ5<^9:^++K][X<Q_PD#V,=QFSU*.:7R1;X41I'O=C)EF8@+G
M&* /7--^*OAO6?%DGA^UU_2KC6+=G1[2&Y1I=T?WU S]Y.-RCE>,XSFNF%I@
M_?;&>GK7AO@?P9XAL_#O@?P9=>';R#_A#=3CNKK6Y98/L4\<'F;98@KF0R3[
MAE612FY]Q.!O]XH A%IMZ,V,8'M3C;9Q\QX].U244 1):[-V';YNO^?Q_E2F
M'AOF;YJDHH B6UVG[S=,=>OUH^S ]>>?3\JEHH 15V_C2T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #)AD4^BB@",KF?IVI%^_\ C_A110 V50DBA1M'H*4=!]0*** %5%*?
M='Y4R*-57A5&X@GCJ3BBB@"1AA/Q']*#$JH,*HP...E%% !L4(WRKQTXZ5)1
=10 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d125524d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cbio-20210714.xsd" xlink:type="simple"/>
    <context id="duration_2021-07-14_to_2021-07-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124105</identifier>
        </entity>
        <period>
            <startDate>2021-07-14</startDate>
            <endDate>2021-07-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2021-07-14_to_2021-07-14">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-07-14_to_2021-07-14"
      id="Hidden_dei_EntityCentralIndexKey">0001124105</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-07-14_to_2021-07-14">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-07-14_to_2021-07-14">2021-07-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-07-14_to_2021-07-14">CATALYST BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-07-14_to_2021-07-14">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-07-14_to_2021-07-14">000-51173</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-07-14_to_2021-07-14">56-2020050</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-07-14_to_2021-07-14">611 Gateway Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2021-07-14_to_2021-07-14">Suite 710</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-07-14_to_2021-07-14">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-07-14_to_2021-07-14">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-07-14_to_2021-07-14">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-07-14_to_2021-07-14">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-07-14_to_2021-07-14">871-0761</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-07-14_to_2021-07-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-07-14_to_2021-07-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-07-14_to_2021-07-14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-07-14_to_2021-07-14">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-07-14_to_2021-07-14">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-07-14_to_2021-07-14">CBIO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-07-14_to_2021-07-14">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-07-14_to_2021-07-14">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139866119040584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001124105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 14,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CATALYST BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2020050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">611 Gateway Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">871-0761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CBIO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #;A>]2F(*\R$<$  #6$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)V877/B-A2&K[>_0L-5.Y/$EL-7=@@SQ"&[=+,)C6EWVDXOA"U $UNBDAS@
MW_?($)MNS3'3FV#9TNM'1\?OD3+8*/UJ5IQ;LLU2:6Y;*VO7'SW/Q"N>,7.E
MUES"DX72&;/0U$O/K#5G23$H2[W ][M>QH1L#0?%O:D>#E1N4R'Y5!.39QG3
MNSN>JLUMB[;>;[R(Y<JZ&]YPL&9+'G'[ZWJJH>65*HG(N#1"2:+YXK8UHA_O
M@HX;4/3X3?"-.;HF;BISI5Y=8Y+<MGQ'Q%,>6R?!X.>-ASQ-G1)P_'T0;97O
M= ./K]_5'XK)PV3FS/!0I=]$8E>WK7Z+)'S!\M2^J,UG?IA0 1BKU!1_R6;?
MM^VW2)P;J[+#8"#(A-S_LNTA$$<#@MZ) <%A0%!P[U]44-XSRX8#K39$N]Z@
MYBZ*J1:C 4Y(MRJ1U?!4P#@[O%=Q#D&VA,F$C*45=D<F<K_:$+6!9^$EKJL7
M'P3O]H+!"<&?\_2*T/8%"?R _GNX!VPE8% "!H7>]0F]4+UQ3?X<S8W5L(1_
M(9+7I>1U(=D^(3F""2?%I!]2MJR;(CY^P5+#$8YVR=%&=0[A#H%$LQ3"GO M
M^<)W=42XDN_[E 9MZG<0K$Z)U4'%RI28[=:\C@4?WK_\@D!T2XCN>1!3KH5R
MJ9D02/!:'ESI/2%_^/"A(25[)5OOG'5[X4OADA(@GUA62X;KA*/9Z/'W:$;N
M)L]1.!D_A>/H@DR>PBL$LE]"]L^!G,A8Z;72Q==,(@LA)*'*(>,@\5122XT+
MWX\1NIN2[N8<N@>1<O*49W.NZT!P#4CZRPZEO6N$A_J5#_KG$,W8EDP22#RQ
M$/$^:*?Y&B0[W4O(.-_O^!CAD5/3<PA'2:*Y,1?O%^01^I%G6;N4#9)=2LDG
M2(D-VY&[]"W!."O#IL'_YYQM5"TG+AGE O*V1]% 5O9/<?_^'C!T+:7)3&WJ
M"QXN%\%F9T4B)LD#F$$L3*PPS*HZT+/*0XFY_WB!<ZK5FY!Q_8+CFN$(0ZLJ
M!,4]_GNTJ3(6*M@?8GW25!H4;]I^'UW=JG!0W.^+U1S!#O4T"B[P8[?C_X2A
M5'6"X@;_J&*(RG2E).9R#2+]'KWT>UVL<-&J*%#<O+]I82V7$)HLR^7!X4PM
M%2[4M >B526@N(U'*A6QL$(NR5=(<"U86LN#JS3Q!%4A"'#7GFI>A(?#%[;?
M!L%N$;:@SXM%_?HUZ#62504@P-WZ/V038W(@:P3$91L!C[;J#3;-XUR[SX\&
M<S(3-JW]_!I$W R+K8J*7S&JRNX#W)]GFB4NNZ)=-E>UN=4@$,+^#".I'#W
MW;>,SW@;KYA<\I,;QP:AIU%T/_H%8ZJL/#C+RL<9UTL7I4^@ .4,5F'-9.U1
MI$'P9#IY1Z=4=^+_RMP;#4GY H3\JQ[HZOTA>M^P:ET<7.?*PC&XN%QQ!JGN
M.L#SA5+VO>'.PN6_,H;_ %!+ P04    " #;A>]2GZ ;\+$"  #B#   #0
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M/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #;A>]2!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -N%
M[U(';!?7[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( -N%[U*97)PC$ 8  )PG   3              "
M <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ VX7O4IB"O,A'
M!   UA   !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( -N%[U*?H!OPL0(  .(,   -              "
M 8L,  !X;"]S='EL97,N>&UL4$L! A0#%     @ VX7O4I>*NQS     $P(
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9>&UL4$L%!@     )  D /@(  .L3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d125524d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d125524d8k.htm">d125524d8k.htm</File>
    <File>cbio-20210714.xsd</File>
    <File>cbio-20210714_lab.xml</File>
    <File>cbio-20210714_pre.xml</File>
    <File>d125524dex101.htm</File>
    <File>d125524dex102.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d125524d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d125524d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cbio-20210714_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cbio-20210714_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cbio-20210714.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cbio",
   "nsuri": "http://www.catalystbiosciences.com/20210714",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d125524d8k.htm",
      "contextRef": "duration_2021-07-14_to_2021-07-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d125524d8k.htm",
      "contextRef": "duration_2021-07-14_to_2021-07-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.catalystbiosciences.com//20210714/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-21-216469-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-216469-xbrl.zip
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MA&;Q1W]AS;4YM]7%0XD17A[3?.E@TL-=.3Q6 %T":=W@HF_#LL&Z>3R<+UG
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M$#_(9>?^\\VZFA0VQ"V]W;M(J9SQ-GY!F>M(+U17=%@%P]MY[M+$^^A;T+F
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M]9=-^N\3.8\V*WS![%W,>T06=+SCMO--N]V1P>X3?($Z?$GO7?]?4$L#!!0
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M98H%:ZF@(V+I"1YY7%:A'WFU*C#H\8"M6,K!B],D3ID2<71X4C<.$Q:M]X[
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MCB)"" Y+EH^DFW)I!QR#-K)8P)5F?*  (S9)N3*AG?(D8!Z^7 FU-"=K&-&
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M,C4U,C1D.&LN:'1M4$L! A0#%     @ VX7O4O=]PF;C'0  ?GT  !$
M         ( ! "0  &0Q,C4U,C1D97@Q,#$N:'1M4$L! A0#%     @ VX7O
M4@; HT]N"0  ["(  !$              ( !$D(  &0Q,C4U,C1D97@Q,#(N
9:'1M4$L%!@     &  8 ?P$  *]+      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
